













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 







An Investigation of Dementia Screening Tools in a Cohort 












Doctorate in Clinical Psychology 
 









D. Clin. Psychol. Declaration of own work 
 
This sheet must be filled in (each box ticked to show that the condition has been met), signed and dated, and 
included with all assessments - work will not be marked unless this is done  
 
Name:    Laura Williams 
  
Assessed work:   Thesis  
 
Title of work:  An Investigation of Dementia Screening Tools in a Cohort with Down Syndrome 
and Intellectual Disability 
 
 
I confirm that all this work is my own except where indicated, and that I have:  

Read and understood the Plagiarism Rules and Regulations in the Programme Handbook  
Composed and undertaken the work myself       
Clearly referenced/listed all sources as appropriate 
Referenced and put in inverted commas any quoted text of more than three words (from books, web, etc)   
Given the sources of all pictures, data etc. that are not my own      
Not made undue use of essay(s) of any other student(s) either past or present (or where used,  
this has been referenced appropriately)         
 
Not sought or used the help of any external professional agencies for the work (or where used,  
this has been referenced appropriately)         
 
Not submitted the work for any other degree or professional qualification except as specified  
 
Acknowledged in appropriate places any help that I have received from others (e.g. fellow students, 
technicians, statisticians, external sources)         
 
Complied with other plagiarism criteria specified in the Programme Handbook    
I understand that any false claim for this work will be penalised in accordance with the University  




Signature  L Williams    Date 11.09.15  
 
Please note:  
 
a) If you need further guidance on plagiarism, you can:  
 
i/ Speak to your director of studies or supervisor  
 





b) Referencing for most assessed work should be in the format of the BPS style guide, which is freely available 





Firstly, I would like to thank the Psychology department in NHS Fife. It has been a nurturing 
and influential place to train. In particular, I wish to thank Dr Alison Robertson. I have 
benefitted greatly and learned much from your approach. I would also like to thank Dr Jill 
Jones, whose support and containment over the course of the project has been invaluable. To 
my academic supervisors, Dr Ken MacMahon and Dr Emily Newman, thank you for your 
guidance throughout.  
  
To the Fife trainees, past and present. Our shared experience has got me to the finish line. 
Thank you for always being there to turn to.  
 
To my friends and family, Mum and Dad.  I want to thank you for all the many and varied 
ways you have each contributed to this outcome. This would not have been possible without 
you.  
 
The topic of my thesis has mirrored life over recent months. This reflection has been both 
confronting and a motivation. To those in my family who knew and know the pain of dementia.  
 
Finally, to Matty and Ella. Thank you for always keeping me grounded in our everyday. This 







1. THESIS ABSTRACT 
 
Objectives: The following thesis is presented within two separate pieces of work. A systematic 
literature review (SLR) aimed to evaluate the individual characteristics and psychometric 
properties of four dementia screening tools. These were the Dementia Questionnaire for People 
with  Learning Disabilities (DLD) (Evenhuis, 2007), the Dementia Scale for Down Syndrome 
(DSDS) (Gedye, 1995), the Dementia Screening Questionnaire for Individuals with Intellectual 
Disabilities (DSQIID) (Deb et al, 2007a) and the Adaptive Behaviour Dementia Questionnaire 
(ABDQ) (Prasher et al, 2004). The empirical research (ER) aimed to evaluate the clinical utility 
and longitudinal accuracy of two of these tools; the DLD and the ABDQ in a clinical population 
with intellectual disability (ID) and Down syndrome (DS).  
Methods: For the SLR a comprehensive list of electronic academic databases were searched 
to identify studies which included information relating to the psychometric properties of the 
DLD, DSDS, DSQIID and the ABDQ. Information within the studies was then extracted and 
rated using two quality assessment measures. These were the Characteristics of Assessment 
Instruments for Psychiatric Disorders in Persons with Intellectual Developmental Disabilities 
(CAPS-IDD) (Zeilinger et al, 2013b) and the Qualsyst (Kmet, 2004). For the ER, a repeated 
measures MANOVA was used to assess change over time between two groups of people with 
intellectual disabilities and Down syndrome; one with dementia and one without.  
Results: In the SLR, 16 studies were identified and rated using the CAPS-IDD and the 
Qualsyst. Detailed information related to the dementia screening tools and quality ratings of 
the papers are provided. 
In the ER both the ABDQ and the DLD demonstrated a clear difference between those who 
develop dementia and those who do not, with those in the ‘dementia’ group exhibiting 
increasing scores over time.  
5 
Conclusions: The SLR concludes that the evidence base for these dementia screening tools 
remain limited. The largest evidence base was evidenced for the DLD.  
The ER concludes that the ABDQ and the DLD are useful tools to differentiate between those 
who develop dementia and those who do not. Further analysis incorporating the exploration of 
individual component items of tools is recommended.  
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THESIS PREFACE AND STRUCTURE 
 
This thesis is about the psychometric properties and utility of tools and questionnaires used to 
screen and diagnose dementia in people with a learning disability. The thesis is presented in a 
portfolio format. The first section comprises a systematic review that focuses on the content 
of psychometric tools and measures used to screen for dementia in this population. The 
second is a piece of empirical research which investigates the use of specific tools, the  
Dementia Questionnaire for people with Intellectual Disabilities (DLD) and the Adaptive 
Behaviour Dementia Questionnaire (ABDQ). The empirical research uses longitudinal data 
from a clinical sample of people with intellectual disability and Down Syndrome. 
 
Both sections follow the publication guidelines for The Journal of Applied Research in 
Intellectual Disabilities (JARID). In addition, The Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA Group, 2009) was used to inform the methods 
employed in writing the systematic review. A list of references is included for each separate 
section immediately after the main body of the text for each. The guidelines for publication in 









A Systematic Review of the Characteristics and Psychometric Properties of 
Four Assessment Tools for Dementia Screening in People with Intellectual 
Disabilities   
Laura Williams, Jill Jones, Ken McMahon, Emily Newman 




Background: There are a number of assessment tools available to support the process of 
diagnosing dementia in individuals with intellectual disability (ID). This review aimed to 
evaluate the characteristics and psychometric properties of four assessment tools that are 
recommended in clinical practice for this purpose.  
Methods: A systematic literature search across five databases (CINAHL, PsycInfo, Medline, 
Scopus and Web of Science) was conducted. Relevant studies were identified and selected 
using defined inclusion/exclusion criteria. 26 full-text articles were hand-searched. After 
selection, 16 studies were rated using the Characteristics of Assessment Instruments for 
Psychiatric Disorders in Persons with Intellectual Disabilities (CAPS-IDD) (Zeilinger et al., 
2013b). The CAPS-IDD provided a structured method of summarising the psychometric 
properties and conceptual and measurement information regarding the dementia screening 
tools. 
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Additionally, the individual papers were rated using the Quality Assessment Criteria for 
Evaluating Primary Research Papers from a Variety of Fields (Qualsyst). A proportion of 
papers were rated independently by two researchers, as were two of the screening tools.  
Results: In total, 104 studies were identified from initial search criteria. After excluding 
duplicates, screening titles and abstracts, a total of 26 studies remained and these were 
retrieved in full-text. Of these, 16 papers met the criteria for inclusion. The review 
highlighted a limited literature base for all screening tools, other than the DLD. The quality 
of the papers used to evidence them were also limited in quality. 
Conclusions: The review demonstrates the evidence base for the four dementia screening 
tools remains limited. The DLD has the largest evidence base. Further validation studies 
would allow for greater understanding of the psychometric properties and accuracy of the 
tools. 
Keywords: Dementia, Intellectual disability, Assessment, Screening, Systematic review 
___________________________________________________________________________ 
1. Introduction 
The ICD-10 Classification of Mental and Behavioural Disorders guidelines (World Health 
Organisation, 1992) define dementia as ‘a syndrome due to disease of the brain, usually of 
chronic or progressive nature, in which there is a disturbance of multiple higher cortical 
functions including memory, thinking, orientation, comprehension, calculation, learning 
capacity, language and judgement. The impairments of cognitive function are commonly 
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accompanied, and occasionally preceded, by deterioration in emotional control, social 
behaviour, or motivation’. There is no modified definition of dementia for those with an 
intellectual disability (ID). Dementia is not a disease in itself, but rather the term used to 
describe a number of symptoms and features which co-exist in an accepted pattern of brain 
degeneration. Dementia is caused by a number of conditions and often these specific ‘types’ 
of dementia are named after their cause. Common types of dementia include Alzheimer’s 
disease, vascular dementia, dementia with lewy bodies, frontotemporal dementia and mixed 
dementia where both Alzheimer’s and vascular features can be observed  (Dening and Babu 
Sandilyan, 2015). 
 
There is no one accepted psychometric tool for the assessment of dementia in people with ID, 
either observer-rated or self report. Neuropsychological tools often used to screen for 
dementia in the general adult population such as the Mini Mental State Examination (MMSE) 
(Folstein, 1987) or the Addenbrookes Cognitive Examination – 3rd Edition (ACE) (Hodges, 
2012) cannot be used for people with ID as they assume a pre-morbid level of functioning 
within the average range; screening using such tools in people with ID would result in 
difficulties delineating pre-existing cognitive impairment from that associated with a 
dementing process (Deb et al, 2007a). For these reasons many researchers regard tests and 
criteria available for people without ID to be not applicable to those with ID (Prasher et al, 
2004). One further key difficulty in screening and diagnosing dementia in this population is 
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the greater probability of physical health conditions in people with ID that can in some cases 
mimic dementia (Deb et al., 2007b). In those with Down Syndrome (DS), the risk of developing 
these health conditions, which include cardiac problems, thyroid disorders, sensory 
impairments, reduced muscle tone and Alzheimer’s type dementia (ATD), at an 
earlier age is increased (Smith, 2001). This has major implications for potential differential 
diagnoses and what might usefully be included within screening and diagnostic tests as part 
of the wider diagnostic process.  
 
1.1 Screening in Intellectual Disability 
Given this context, there has been a concerted effort among clinicians working with 
individuals with ID to develop tools that bridge the existing gaps and allow for accurate 
screening and timely diagnosis. In a recent systematic review, Zeilinger et al. (2013a) found 
114 available tools for the purpose of dementia screening.  Of these, 79 instruments were to 
be completed directly by the person with ID and 35 were informant-based instruments. An 
additional four test batteries were identified.  
 
Zeilinger et al. (2013a) noted that the intention of the review was to provide an overview of 
available tools, acknowledging that they did not evaluate the instruments collected or 
examine the psychometric properties or other characteristics. However, reviewing in more 
detail the strengths and limitations across the available tools may allow for a comparison 
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between specific tools. Furthermore, it might highlight specific areas for empirical research. 
Thorough analysis of the individual component parts or items included in the tools might 
identify those that are most likely to be helpful in dementia screening in this population. It 
has been argued that it is unlikely that a single tool can be found to accurately and reliably 
detect dementia in people with ID (Prasher et al, 1995). However, if the most predictive 
component sub-scales or individual items of the existing individual tools can be integrated, 
this may lead towards the development of a more reliable dementia screening tool in ID 
populations.  
 
The systematic review presented here replicates and extends the search strategy used by 
Zeilinger et al. (2013a) to identify studies which have used any of four specific informant- 
based assessment tools. The tools chosen for review here are highlighted in the joint 
British Psychological Society (BPS) and Royal College of Psychiatrists (RCP) guideline 
‘Dementia and People with Intellectual Disabilities: Guidance on the assessment, diagnosis, 
interventions and support of people with intellectual disabilities who develop dementia’ 
(BPS, 2009), as examples of best practice for assessing dementia. These are tools clinicians 
are likely to consider when screening for dementia in people with ID within a UK context 
and include the Dementia Questionnaire for People with Learning Disabilities (DLD; 
Evenhuis et al, 2007); The Dementia Scale for Down Syndrome (DSDS; Gedye, 1995); 
Adaptive Behaviour Dementia Questionnaire (ABDQ; Prasher et al, 2004); Dementia 
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Screening Questionnaire for Individuals with Intellectual Disabilities (DSQIID; Deb et al, 
2007a). 
 
The DLD (Evenhuis, 2007) formerly known as the Dementia Questionnaire for People with  
Mental Retardation (DMR) is a screening tool used to assist in the early detection of 
dementia in people with a learning disability. First developed in 1980, it is completed by a 
family member or carer often assisted by a healthcare professional. The DLD consists of 50 
items which are sub-divided into eight separate subscales. The following subscales make up 
the Sum of Cognitive Scores: short term memory; long-term memory; spatial and temporal 
orientation. The remaining sub scales make up the Sum of Social Scores: speech; practical 
skills; mood; activity and interest and behavioural disturbance. The items assess for the 
presence of a particular behaviour corresponding to the individual subscales using a Likert 
scale with three response categories: 0 points=no deficit, 1 point =moderate deficit, 2 points = 
severe deficit; and therefore higher scores correspond to more severe deterioration. For  
example, item 2 states remembers where he/she put something away a short time ago (no 
longer than half an hour ago), can be scored 0 = normally yes, 1=sometimes and 2=normally 
no. The DLD is widely used throughout the United Kingdom and Europe (BPS, 2009). 
 
The DSDS (Gedye, 1995) was developed to provide a means to assess cognitive deterioration 
in adults with prior cognitive impairment. The tool was intended to specifically assess for 
dementia in people with DS, though the NICE guidelines (2006) suggest it can also be used 
with people with ID who do not have DS. It is a 60-item informant based tool and the items 
are grouped into three separate categories identifying characteristics of dementia as ‘early 
stage’, ‘middle stage’ and ‘late stage’. As an example, to meet criteria for ‘early stage’, the 
16 
person must demonstrate a minimum of three losses in the cognitive area, defined as the 
Cognitive Cut-off score (Jozsvai et al., 2009).  
 
The DSQIID (Deb et al, 2007a) is an informant-rated dementia screening tool comprising of 
43 questions across three separate sections. In Part 1: Level of ‘Best’ Ability, the DSQIID 
attempts to give an indication of both the presence of dementia and its severity by 
categorising it as early, middle or late stage. Part 2 and Part 3 comprise a time course of the 
persons decline and a section detailing  information on differential diagnosis.   
 
The ABDQ (Prasher et al, 2004) is a 15-item questionnaire designed to detect change in 
adaptive behavior. It was developed from an earlier screening tool known as the AAMD 
Adaptive Behaviour Scale (Nihira et al, 1974) and was intended specifically for screening for 
dementia in Alzheimer’s disease. It compares a person’s current presentation to his/her 
previous level of social functioning. The tool provides cut-offs for dementia and a rating on 
severity as follows: mild – ≥ 78-89, moderate – ≥ 90-99, severe - ≥100). The ABDQ also 
gives criteria for the presence of Alzheimer’s disease specifically and a rating on severity.  
 
Zeilinger et al., (2013a) recommended that all dementia screening tools identified in their 
review should be evaluated to identify their characteristics and psychometric properties. The 
current review represents a first step towards this recommendation by reviewing these four 
recommended tools outlined above. Specifically, this review aims to identify 1) what is the 
sensitivity and reliability of the four dementia screening tools? 2) what are the characteristics 
of the tools such as aetiology of the target group and ease of use?  3) what is the evidence 
base for the use of these tools with an ID population? and 4) what is the quality of the studies 
17 




2.1 Literature Search 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA  
Group, 2009) was used to inform the methods employed in writing this review. A systematic 
literature search was conducted across the following databases: CINAHL, PsycInfo, Medline, 
Scopus and Web of Science. The search string included the following terms for (1) output of 
interest (e.g. assessment instrument, diagnostics or screening), (2) measure of interest 
(dementia, Alzheimer’s disease). The search was performed once for the (3) specified 
population (intellectual disability, mental retardation, learning disability) and a second time 
for persons with Down syndrome (Down syndrome, trisomy 21). The final search string 
included the inclusion of four specific assessment measures highlighted as best practice 
measures for use in screening dementia in this population (British Psychological Society, 
2009). Table 1. shows the detailed search strategy using Boolean operators. The final search 
string included all terms for output, measure, population and specific tools (1 AND 2 




2.2 Inclusion and Exclusion Criteria 
Relevant studies were identified and selected on the basis of the following inclusion 
criteria: 1) studies focused on assessing dementia in people with ID, and 2) studies in which 
one of four specific measures has been used (i.e. DLD, DSDS, DSQIID, ABDQ). The present 
review used five exclusion criteria: 1) classification systems used to make a diagnosis such 
as the Diagnostic and Statistical Manual of Mental Disorders (DSM), 2) scales focused on 
mood disorders or Parkinsons disease and 3) medical tests (e.g. genetic marker tests, PET, 
fMRI), (taken from Zeilinger et al, 2013a) 4) studies that used the DLD, DSDS, DSQIID 
or the ABDQ but did not report on their psychometric properties and 5) existing reviews or 
assessment guidelines for assessment of dementia in people with learning disability which 
discussed assessment instruments. 
 
2.3 Coding of Dementia Screening Tools and Relevant Studies 
Within this review a two-step process of rating was adopted. Firstly, all studies identifying 
the use of at least one of the dementia screening tools selected for inclusion in the search (i.e. 
DLD, DSDS, DSQIID, ABDQ) were collated. Information about the tools characteristics and 
psychometric properties, contained within these studies, was extracted and rated according to 
the Characteristics of Assessment Instruments in Persons with Intellectual Developmental 
Disorders (CAPS-IDD) (Zeilinger et al, 2013b). The CAPS-IDD evaluates and describes 
instruments that identify psychiatric disorder among people with intellectual developmental 
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disability. It is sub-divided into two sections known as Part 1: Conceptual and Measurement 
Model and Part 2: Psychometric Properties. In Part 1: Conceptual and Measurement Model 
there are three further sub-sections. These are Section B: Basic Information, Section T:Test 
Development and Section C Measurement Characteristics. In Part 2: Psychometric Properties 
there are five further sub-sections. There are Section V:Validity, Section R: Reliability, 
Section O: Objectivity of Application, Section N: Objectivity of Interpretation, Norming and 
Fairness. A comprehensive review of the development of the CAPS-IDD and further 
information relating to individual subsections can be found in Zeilinger et al. (2013b).  The 
aim of the CAPS-IDD is to provide a structured overview of instruments and allow for 
comparison across measures on both quality and individual features. The coded CAPS-IDD 
schedules for the four measures included within this review can be found in the Appendix 
section (Appendix 6).  Once the screening tools had been coded using the CAPS-IDD, the 
second part of the review involved rating the quality of the individual papers related to the 
four measures. This was done using the Standard Quality Assessment Criteria for Evaluating 
Primary Research Papers from a Variety of Fields (Qualsyst) (Kmet et al, 2004).  Qualsyst is 
a structured and replicable system for scoring, in this case quantitative studies, which 
aims to ensure a minimum quality standard. The Qualsyst includes two checklists for 
both quantitative and qualitative studies. For the present review, the checklist for assessing 
the quality of quantitative studies was used and includes 14 items such as ‘is the 
question/objective sufficiently described?’, ‘sample size appropriate’ and ‘conclusions 
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supported by the results’. The quality assessment score is obtained by rating each study 
according to the degree to which they met these 14 criteria. Possible scores included ‘yes’=2, 
‘partial’=1 and ‘no’=0. Items that were not applicable to a particular study design were 
marked as such and excluded from the total summary score. To obtain the final summary 
score the applicable item scores were then added together and divided by the total possible 
score of 28. For further information on scoring or for a full description of the 14 criteria 
please see Kmet et al (2004)’.  
 
3. Results 
3.1 Literature Search 
The literature search yielded a total of 106 records. After excluding duplicates, 77 remained.  
These were screened by reviewing titles and abstracts to check the relevance of each study. A 
Further 51 records were excluded at this stage, leaving a total of 26 studies reviewed as full 
text articles. This yielded a total of 16 studies for inclusion in the final review. Of these, 13 
studies referred to the DLD, 1 to the ABDQ, and 1 to the DSQIID. One paper referred to both 
the DLD and the DSDS. A substantial proportion of the studies included (6/16, 37.5%) 
reported single completion, rather than longitudinal data. Figure1. gives an overview of the 
search strategy and its results.  
 
Using the CAPS-IDD (Zeilinger et al., 2013b) to extract and rate the four tools from the 
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available papers yielded detailed information relating to individual characteristics as well as 
the psychometric properties.  Individual characteristics within the CAPS-IDD refers to basic  
information such as the concept to measured, level of ID and age of the target group, as well 
as information on test development and measurement. Summary evidence from the CAPS 
IDD are provided in the following tables for each of the four screening tools, Tables 1, 2, 3, 
and 4. The Qualsyst (Kmet et al, 2004) gave a further indication of the quality of the studies 
identified. Fifty percent sample of the included papers were rated by two researchers 
independently. There was substantial agreement between the two raters (k=0.788 (p<0.0001), 
95% CI (0.681 – 0.895) (Landis and Koch, 1977). Final Qualsyst ratings are provided in 
Appendix 1.  
22 




























Records identified through 
database searching  
(n = 104) 
Additional records identified 
through other sources  
(n = 2) 
Total records  
(n =106) 
Duplicates excluded  
(n = 29) 
Records excluded  
(n = 51) 
Records screened: title 
and abstract  
(n = 77) 
Full-text articles assessed  
(n =26) 
Studies included  
(n =16) 
Records excluded (n = 10) 
 
No psychometric info -5 
Different version of tool – 1 
No confirmed diagnosis-1 





3.2 Quality Assessment 
 
CAPS-IDD Summary of Findings Table – Dementia Questionnaire for Persons with Learning Disabilities (DLD) 
 
Part 1. Conceptual and Measurement Model 
 
B: Basic Information 
B1: Concept to be measured: Dementia 
B2: Level of IDD: Mild. Moderate, Severe 
B3: Aetiology of target group: None 
B4: Age of Target group: Adulthood, Elderly 
B5: Primary purpose/recommendation for use: Screening 
B6: Available modes of administration: Single setting, paper-pencil, 
communication aids not available 
B7: Respondent requirements: Person with IDD is not a respondent. Caregiver 
(e.g. direct care staff, family carer, teacher) 
B8: Competence Level needed for administration: Psychologist, Psychiatrist 
Summary of Findings 
The DLD is a dementia screening tool for use in the mild, moderate, severe 
range of IDD. It is not applicable to those with profound IDD (with a 
developmental age of lower than 2 years) or to persons with severe IDD (with a 
developmental age of 2-3 years) combined with severe other disabilities such as 
motor impairment or hearing loss. Patients with Down syndrome were 
excluded from some studies but included in others. A first evaluation involved 
98 ‘ageing residents’. Another study population consisted of 271 ‘older people’. 
Pearson clinical state the age range as adult. The DLD is a screening 
instrument to be used as part of a comprehensive assessment to identify those 
who require further specialist diagnostic assessment. It is administered single 
setting using paper and pencil. There is no computer based alternative or 
accompanying visual aids or symbols. The person with IDD is not a 
respondent. It should be completed by a family or staff member who is familiar 
with the person. Questions should be guided by an appropriately qualified 
professional.  
T: Test Development 
T1: Main underlying theory for generating items: Behavioural, other (cognitive) 
T2: Experts involved in test development: Mental health professionals 
T3: Based on classification models: DSM-IV 
 
Summary of Findings 
The main underlying theory used in generating the items is behavioural and 
cognitive with the items organised into Sum of Cognitive Scores and Sum of 
Social Scores. The developers of the tool are mental health professionals. The 
tool has been based on the DSM-III-R and later the DSM-IV criteria. 
C: Measurement  
C1: Item content: Problem behaviour, adaptive behaviour, emotional e.g. 
feelings, cognitive abilities 
C2: Item coding: Polytomous (includes Likert scale) Presence (does the person 
show the symptom/behaviour at all) 
C3: Timeframe: More than one month  but less than 6 months 
C4: Floor/ceiling effects: No information 
C5: Responsiveness: Yes, recommended to detect changes 
 
Summary of Findings 
The items are organised into Sum of Cognitive Scores (SCS) and Sum of Social 
Scores (SOS). The SCS includes short-term memory, long-term memory and 
spatial and temporal orientation. The SOS includes speech, practical skills, 
mood, activity and interest and behavioural disturbance. The response format 
is polytomous and assesses for presence i.e. does the person show the 
symptom/behaviour at all. Most items have three response categories: 0-no 
deficit, 1-moderate deficit, 2 
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severe deficit. Higher scores correspond to more severe deterioration. The 
questionnaire requires that behaviour during approximately the last two 
months be observed and scored. The DLD has been shown to detect change in 
functioning.  
Part 2: Psychometric Properties 
 
V: Validity 
V1: Criterion validity: Sensitivity  
V2: Content validity: No information 
V3: Construct validity: No information 
V4: Face validity: No information 
 
Summary of Findings 
Application of the cut-off criteria agreed resulted in a sensitivity and specificity 
as follows at the 95% confidence level.  
                                  Sensitivity                          Specificity 
70+                           7/7(100%) (59-100)          19/26 (73%) (52-88) 
Down syndrome    8/8(100%) (63-100)          27/36 (75%) (58-88) 
 
Prasher et al (1997), using longitudinal data reported a sensitivity of 60% and 
a specificity of 67%.  
R: Reliability 
R1: Internal consistency: No information 
R2: Reliability: Interrater 
R3: Measurement error: No information 
 
Summary of Findings 
Interrater reliability was measured using the Pearson correlation coefficient 
for the different subscales. These varied between 0.44 and 0.94. Short-term 
memory 0.84, long-term memory 0.87, orientation – speech 0.68, practical 
skills 0.94, mood/activity of interest 0.74. Two correlations were slightly low: 
speech and behavioural disturbance.  
O: Objectivity of Application 
O1: Application: Comprehensive manual available 




Summary of Findings 
A fully comprehensive manual is available (Evenhuis, 2007). Evenhuis, H.M., 
& Kengen M.M.F. & Eurlings. H.A.L. (2007). Dementia Questionnaire for 
People with Learning Disabilities: UK Adaptation of the Dutch Instrument. 
N: Objectivity of Interpretation, Norming and Fairness 
N1: Norms: Level of IDD 
N2: Cut-offs: Rationale and procedures for determining cut-offs present 
N3: Fairness: Other aspects 
 
Summary of Findings 
Normed on mild-moderate IDD population. Provisional cut-offs for single 
completion were determined following the first prospective evaluation study. 
These were re-evaluated following a second study and finalised. In the updated 
manual (Evenhuis, 2007) noted that as the provisional criteria were based on 
single completion their use may have led to unreliable results. Therefore they 
were not included in the manual. The assessment criteria for ‘dementia’ based 
on score change as compared with the original DLD score is: an increase in the 
Sum of Cognitive Scores (SCS) of 7 points or more and/or an increase in the 
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Sum of Social Scores (SOS) of 5 points or more, independent of the original 
level of learning disability. 
F: Feasibility 
F1: Missing values: No information 
F2: Ease of administration/burden: Time needed for completion, reading and/or 
comprehension level, special requirements or requests made of respondent, 
evidence that instrument places no undue physical or emotional strain on 
respondent, time needed for scoring/interpretation 
F3: Value: for health professionals (e.g. psychologist, , psychiatrist, for persons 
with IDD, for caregiver (direct-care staff, family carer) 
F4: Acceptability: for health professional (e.g. psychologist, psychiatrist) 
F5: Availability: Not free, published as test (manual) 
Summary of Findings 
Reading and comprehension level for the respondent is minimal and no special 
requirements or requests are made of them. The instrument places no undue 
physical or emotional strain on the respondent. Pearson clinical state that the 
questionnaire takes 10-20 minutes to complete. The DLD is one of the most 
commonly used tools within the UK and according to the published manual 
(Evenhuis, 2007) is high-ranking in recommendations for diagnostic batteries. 
The tool can be considered an acceptable questionnaire for use by health 
professionals for dementia screening. The questionnaire can be purchased at 
www.pearsonclinical.co.uk. Complete kit price currently £129.50.  
Table 1. Summary Findings for CAPS-IDD – DLD 
 
CAPS-IDD Summary of Findings Table – Dementia Scale for Down Syndrome (DSDS) 
 
Part 1. Conceptual and Measurement Model 
 
B: Basic Information 
B1: Concept to be measured: Dementia 
B2: Level of IDD: Severe, profound 
B3: Aetiology of target group: Trisomy 21 
B4: Age of Target group: Adulthood  
B5: Primary purpose/recommendation for use: Diagnosis 
B6: Available modes of administration: Single setting, paper-pencil, 
communication aids not available 
B7: Respondent requirements: Person with IDD is not a respondent, Health 
professional (e.g. psychologist, psychiatrist, nurse) 
B8: Competence Level needed for administration: Psychologist 
Summary of Findings 
The DSDS was developed as a tool to assess cognitive deterioration in adults 
with prior intellectual developmental disability (IDD). It was specifically 
intended for use with those in the lower ranges of functioning and was 
standardised and validated on individuals with Down syndrome in the severe 
and profound ranges of intellectual functioning. The published manual, in a 
note added in January 2007, states that the tool may or may not be useful for 
individuals in the mild moderate range of functioning and that this would have 
to be confirmed by appropriate studies. However the author noted that tool 
has proven equally sensitive for assessing dementia in developmentally 
disabled adults without DS. The DSDS was designed to diagnose the absence or 
presence of dementia and to rate its severity. It is administered single setting 
using paper and pencil. There is no computer based alternative or 
accompanying visual aids or symbols. The person with IDD is not a 
respondent. The tool relies on information obtained from caregivers in a 
structured interview. The author is clear that only psychologists and 
psychometrists trained in standardised testing and with experience in 
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administering intelligence tests are permitted to use this psychological 
assessment tool.  
T: Test Development 
T1: Main underlying theory for generating items: Behavioural 
T2: Experts involved in test development: Mental health professionals, persons 
with IDD (e.g. focus group, pre-testing)  
T3: Based on classification models: DSM 
 
 
Summary of Findings 
The main underlying theory used in generating the items is behavioural with 
the scale incorporating behaviours commonly found in developmentally 
disabled adults. Other items were included to detect changes in which might 
indicate loss of functioning for that individual. The developers of the tools are 
mental health professionals and persons with IDD were also used in pre-testing 
in a prospective longitudinal study. The tool is consistent with the related DSM 
criteria. 
C: Measurement  
C1: Item content: Problem behaviour 
C2: Item coding: Dichotomous (yes/no; right/wrong), presence (e.g. of a skill, 
problem, symptom, presence (does the person show the behaviour at all) 
C3: Timeframe: 6 months, more than months 
C4: Floor/ceiling effects: No information 
C5: Responsiveness: Yes, recommended to detect changes 
Summary of Findings 
The DSDS contains items that describe behaviours commonly found in 
developmentally disabled adults. Other items have been designed to detect 
changes with represent loss of functioning for that individual. It uses four 
terms to classify these features: typical, non-applicable, present, absent. The 
author of the tool suggests follow-up every 6-12 months to ensure detection of 
potential changes and to accurately detect the time of onset of dementia.   




V1: Criterion validity: Concurrent, Sensitivity 
V2: Content validity: No information 
V3: Construct validity: Other 
V4: Face validity: Face validity rated by author 
 
Summary of Findings 
The author completed a concurrent study on 1993. Dementia assessments were 
completed independently and later compared with the psychiatrist’s dementia 
ratings yielding a kappa coefficient of 0.81. The author reported that evidence 
for content validity was not specifically collected. However noted that DSDS 
items would reflect deterioration in the relevant domains of cognitive 
functioning. One estimate of construct-related validity is the relationship 
between known final outcome and earlier half scores on a test. Half of the 
sample of 60 older adults with Down syndrome progressed from varying levels 
of cognitive ability to being totally unable to perform any tasks requiring 
memory, comprehension or language. 100% of those people had earlier met 
the tools criteria for onset of cognitive decline and progression to middle and 
late stages. Face validity is rated by the author. Deb and Braganza (1999) 
reported a sensitivity of 0.89 and a sensitivity of 0.85.  
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R:Reliability 
R1: Internal consistency: No information 
R2: Reliability: Interrater 
R3: Measurement error: No information 
 
Summary of Findings 





O:Objectivity of Application 
O1: Application: Comprehensive manual available 




Summary of Findings 
A fully comprehensive manual is available. It can be purchased by contacting 
the author, sending the appropriate forms and payment. Details can be found 
on the website www.gedye.ca.  
N: Objectivity of Interpretation, Norming and Fairness 
N1: Norms: Year in which norm sample was tested, size of norm sample, 
important characteristics of norm sample (e.g. representative for target 
population, identify language or ethnic groups, sex, level of IDD 
N2: Cut-offs: Rationale and procedures for determining cut-offs 
N3: Fairness: No information  
 
Summary of Findings 
The tool was initially normed on a sample which included 60 adults with IDD 
and Down syndrome. A group of adults without IDD and Down syndrome. 
Items are grouped within stages: early, middle, late and very late. A complex 
description of scoring criteria is contained within the manual.  
F: Feasibility 
F1: Missing values: Other 
F2: Ease of administration/burden:Other 
F3: Value: For health professionals (e.g. psychologist, psychiatrist), person with 
IDD 
F4: Acceptability: For health professionals (e.g. psychologist) 
F5: Availability: Not free, can be requested from the author 
Summary of Findings 
The author acknowledged missing data but noted that split-half reliability was 
not feasible. The DSDS test booklet was designed for repeated use. This makes 
6 monthly or annual comparisons easier and the author suggests this can aid 
early detection of dementia. The tool should be used by a clinician in a 
structured interview after having studied the manual. It is not a questionnaire 
to be given to informants to complete. The tool is an acceptable questionnaire 
for use by health professionals with the appropriate qualifications. A fully 
comprehensive manual is available. It can be purchased by contacting the 
author, sending the appropriate forms and payment. Details can be found on 
the website www.gedye.ca. 
Table 2. Summary findings CAPS-IDD - DSDS 
 
CAPS-IDD Summary of Findings Table – Dementia Questionnaire for Individuals with Intellectual Disabilities (DSQIID) 
 
Part 1. Conceptual and Measurement Model 
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B: Basic Information 
B1: Concept to be measured: Dementia 
B2: Level of IDD: Mild, Moderate, Severe, Profound 
B3: Aetiology of target group: Trisomy 21 
B4: Age of Target group: Adulthood 
B5: Primary purpose/recommendation for use: Screening 
B6: Available modes of administration: Single setting, paper-pencil, 
communication aids not available 
B7: Respondent requirements: Person with IDD is not a respondent. Caregiver 
(e.g. direct care staff, family, carer, teacher) 
B8: Competence Level needed for administration: Direct care staff, other 
Summary of Findings 
The DSQIID is an observer rated dementia screening tools for use with adults 
with intellectual disabilities. The author suggests that the tool can be used 
equally effectively among all adults with intellectual disabilities, though the 
measure was only tested on a sample of adults with Down syndrome. It is 
administered single setting using paper and pencil. There is no computer based 
alternative or accompanying visual aids or symbols. The person with IDD is not 
a respondent. The DSQIID is observer rated and should be completed by carers 
of people with Down syndrome who have known the person for at least 6 
months in order to be effective. It is also noted that the person should have 
witnessed change since the onset of dementia. The author is clear that the 
questionnaire is for use by carers. They do not specify that the tool should be 
guided by a health professional.  
T: Test Development 
T1: Main underlying theory for generating items: Behavioural 
T2: Experts involved in test development: Mental health professionals, direct 
care staff, family carers 
T3: Based on classification models: ICD 
Summary of Findings 
The main underlying theory used in generating the items is behavioural with 
the measure specifically assessing adaptive behaviour. The developers of the 
tool were mental health professionals, direct care staff and family members. 
Carers of 24 adults with Down syndrome were interviewed to and the data 
analysed to qualitatively derive 53 items for inclusion in the questionnaire. The 
DSQIID has been based on the ICD-10 criteria. 
C: Measurement  
C1: Item content: Problem behaviour 
C2: Item coding: Polytomous (included Likert scale) Presence (e.g. skill, 
problem, symptom) 
C3: Timeframe: 6 months 
C4: Floor/ceiling effects: Other 
C5: Responsiveness: Yes, recommended to detect changes  
Summary of Findings 
The DSQIID is divided into three parts. Part 1. asks about the ‘best’ ability the 
person has or has had. Part 2. contains 43 questions about behaviour or 
symptoms that are usually associated with dementia in adults with Down 
syndrome. It is a polytomous scale and is scored on a four-point scale: ‘always 
has been the case’, ‘always but worse’, ‘new symptoms’ and ‘does not apply’. 
Part 3. contains 10 questions, all of which are comparative; for example 
‘speaks(signs) less and ‘seems generally more tired’. A response of ‘yes’ is 
scored 1 and a response of ‘no’ is scored 0. Scores from part 2 and 3 are added 
to give a total score. The 53 items include factors such as loss of memory, 
confusion, loss of skills, social withdrawal, behavioural changes, psychological 
symptoms, sleep disturbance and speech abnormalities.  The authors state that 
the respondent should only report those behaviours which that have existed for 
at least 6 months, though they acknowledge that they did not themselves apply 
this criterion. The paper states that the Likert scale scoring system was adopted 
to overcome the floor effect of the existing dementia screening tools which score 
current behaviour. The DSQIID measures changes in behaviour. 
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V1: Criterion validity: Area under the ROC, sensitivity/specificty 
V2: Content validity: Concerning relevance of items, concerning 
comprehensiveness of items 
V3: Construct validity: Factor analysis (CTT) 
V4: Face validity: Face validity rated by the authors, face validity rated by 
caregiver 
 
Summary of Findings 
Receiver operating characteristic (ROC) analysis was used on data from those 
who were examined by a clinician. Use of an overall score of 20 as a screening 
cut-off provided a sensitivity of 0.92, specificity 0.97, a postitive likelihood ratio 
of 31 and a negative likelihood ratio of 0.08. The authors reported that the 
checked whether any items were repeatedly missed by carers or providing the 
same answer. When preparing the questions they took into account 
interpretability, ambiguity, carers reading level, avoidance of double-barrelled 
questions, jargon, value-laden words, positive and negative wording and the 
length of the items. By adopting a ‘bottom up’ approach that incorporated the 
views of carers, the authors assert that this has ensured good face validity. A 
forced four factor analysis was conducted which included over 57% of the 
variance. The last 10 items of the questionnaire were excluded from this 
analysis as they were rated on a two-point system.  
 
R:Reliability 
R1: Internal consistency: Cronbach’s alpha (CTT) 
R2: Reliability: Test-retest, interrater 
R3: Measurement error: Test-retest, interrater 
 
Summary of Findings 
Chronbacks alpha for all 53 items on the DSQIID is 0.91. The authors also 
report that they used data from all participants to analyse test-retest and 
interrater reliability. The intraclass correlation for the test-retest reliability 
(n=52) was 0.95.  
O:Objectivity of Application 
O1: Application: Some instructions available (e.g. published paper)  




Summary of Findings 
The published paper (Deb et al, 2007a) gives brief instructions on the structure, 
administration and scoring.   
N: Objectivity of Interpretation, Norming and Fairness 
N1: Norms: Year in which the norm sample was tested, size of norm sample, 
important characteristics of norm sample, aetiology (e.g. specific syndromes),  
N2: Cut-offs: Rationale and procedures for determining cut-offs  
N3: Fairness: Other aspects 
 
Summary of Findings 
The DSQIID was administered to carers of 193 adults with Down syndrome , 
117 whom were examined by clinicians who confirmed a diagnosis of dementia 
for 49 according to modified ICD-10 criteria. A total cut-off score of 20 is 
recommended for screening for adults dementia among adults with Down 
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syndrome. However, the authors acknowledge that there may be different cut-
off scores for people with severe and profound intellectual disabilities. 
 
F: Feasibility 
F1: Missing values: No information  
F2: Ease of administration/burden: Time needed for completion, reading and/or 
comprehension level, special requirements or requests made of respondent, 
evidence that instrument places no undue physical or emotional strain on 
respondent, time needed for scoring/interpretation, easy to understand 
instructions 
F3: Value: for health professionals (e.g. psychologist, , psychiatrist, for persons 
with IDD, for caregiver (direct-care staff, family carer) 
F4: Acceptability: for health professional (e.g. psychologist, psychiatrist) 
F5: Availability: Available for free, can be requested from author  
Summary of Findings 
Reading and comprehension level for the respondent is minimal and no special 
requirements or requests are made of them. The instrument places no undue 
physical or emotional strain on the respondent. The authors report that the 
DSQIID is easy to use, takes approximately 10-15 minutes to complete and can 
be administered at home or in a clinic setting. They note that the screening cut-
off is constant rather than variable and applies to all levels of IDD. They note 
that the tool is acceptable for health professionals, carers and the individual 
and that its value is in timely diagnosis and treatment. The questionnaire can 
be found online for free at the following address: 
http://www.birmingham.ac.uk/Documents/college-
les/psych/ld/LDDementiaScreeningQuestionnaire.pdf 
Table 3. Summary findings CAPS-IDD - DSQIID 
 
CAPS-IDD Summary of Findings Table – Adaptive Behaviour Dementia Questionnaire (ABDQ) 
 
Part 1. Conceptual and Measurement Model 
 
B: Basic Information 
B1: Concept to be measured: Dementia 
B2: Level of IDD: Mild, Moderate, Severe, Profound 
B3: Aetiology of target group: Trisomy 21 
B4: Age of Target group: Adulthood 
B5: Primary purpose/recommendation for use: Screening 
B6: Available modes of administration: Single setting, paper-pencil, 
communication aids not available 
B7: Respondent requirements: Person with IDD is not a respondent. 
Caregiver (e.g. direct care staff, family, carer, teacher) 
B8: Competence Level needed for administration: None 
Summary of Findings 
The ABDQ is a dementia screening tool designed specifically to screen for 
dementia in Alzheimer’s disease (DAD) in adults with Down syndrome 
(DS).  The ABDQ can be used in all adults, irrespective of level of IDD. The 
questionnaire specifically targeted individuals with Down Syndrome. It is 
administered single setting using paper and pencil. There is no computer 
based alternative or accompanying visual aids or symbols. The person 
with IDD is not a respondent. The person with IDD is not a respondent. It 
should be completed by the principal carer and the author noted that this 
can be either a family member or paid carer. The author does not specify 
a specific competence level to be able to administer the measure, though 
does state that it can be conducted as a semi-interview assessment with 
the interviewer filling out the scale item-by-item while obtaining 
information from the person familiar with the person.  
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T: Test Development 
T1: Main underlying theory for generating items: Behavioural 
T2: Experts involved in test development: Mental health professionals 
T3: Based on classification models: ICD 
 
Summary of Findings 
The main underlying theory used in generating the items is behavioural 
with the questionnaire specifically assessing adaptive behaviour. The 
developers of the tool are mental health professionals. The tool has been 
based on the ICD-10 criteria. 
C: Measurement  
C1: Item content: Adaptive behaviour 
C2: Item coding: Polytomous (included Likert scale) Presence (e.g. skill, 
problem, symptom) 
C3: Timeframe: More than 6 months 
C4: Floor/ceiling effects: No information 
C5: Responsiveness: Yes, recommended to detect changes  
 
 
Summary of Findings 
The ABDQ consists of 15 questions which assess adaptive behaviour. The 
response format is polytomous and assesses for presence i.e. of a skill or 
problem. Most items have three response categories and higher scores 
indicate increasing severity of dementia in AD. No dementia in AD - <78, 
mild dementia in AD – 78-89, Moderate dementia in AD – 90-99, Severe 
dementia in AD ≥100. The author reported that the persons included in 
the study were being followed up on an annual basis and soothe 
behaviour being observed was across a year period. The ABDQ has been 
shown to detect change in functioning.  
 




V1: Criterion validity: Sensitivity/specificity 
V2: Content validity: Concerning relevance of items, Concerning 
comprehensiveness of items 
V3: Construct validity: Exploratory Factor analysis (for CTT) 
V4: Face validity: Face validity rated by the authors 
 
Summary of Findings 
Using a cut-off score of greater than 78, sensitivity for the ABDQ in 
detecting DAD was 89% and a specificity of 94%. The overall percentage 
correct identification (accuracy) of DAD and non dementia in AD cases 
was 92%. During development of the ABDQ 31 items appeared to be 
predictors for dementia in AD. The authors attempted to remove the least 
amount of items while still obtaining some useful results using logistic 
regression analysis. After examining correlations between 31 items it 
was possible to reduce further the number of items to 16. One further 
question was later excluded as from the analysis as significant proportion 
(15%) of carers had difficulty answering it. The author notes that the 
items included in the ABDQ were derived from the Adaptive Behaviour 
Scale (ABS) (Nihara et al, 1974) and therefore does have good face 
validity.  
R:Reliability Summary of Findings 
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R1: Internal consistency: Split-half (CTT) 
R2: Reliability: Interrater 
R3: Measurement error: No information 
 
In order to verify face validity of the ABDQ, split half validity was 
undertaken. The results of the binary logistic regression using the new 
weighted items gave an overall accuracy of 94%, which is comparable to 
that found previously. With regard to interrater reliability, the total 
weighted score from one carer was correlated with that reported by the 
second carer in 36 cases. Pearson correlation was 0.954 (p<.01). This 
would suggest good interrater reliability.  
O:Objectivity of Application 
O1: Application: Some instructions available (e.g. published paper)  




Summary of Findings 
The published paper (Prasher et al, 2004) gives brief instructions on the 
structure, administration and scoring.   
N: Objectivity of Interpretation, Norming and Fairness 
N1: Norms: Yea r in which the norm sample was tested, size of norm 
sample, important characteristics of norm sample, sex, level of IDD, 
chronological age, aetiology (e.g. specific syndromes), weightings 
determined using ICD-10 criteria 
N2: Cut-offs: Rationale and procedures for determining cut-offs  
N3: Fairness: Gender, age 
 
Summary of Findings 
In the published paper (Prasher et al, 2004) it is reported that 150 adults 
participated. Of these 83 (55%) were male and 67 (45%) were female. 
The mean age of the sample at the start was 44 years (SD11.46, range 16-
76 years). All individuals had physical stigmata of DS with 92% trisomy 
21 (of 135 tested) and 6% of those tested had translocated form of DS. 
Sixty (40%) were resident in their family home, 57(38%) in community 
group homes and 33(22%) resided in the hospital. According to ICD-10 
criteria (WHO, 1992) for severity of ID, 27 (18%) of individuals had mild 
ID, 104 (69%) moderate and 19 (13%) severe ID. The ABDQ has not been 
tested on non-DS adults with dementia, in persons with deterioration in 
physical health or onset of non-DAD psychiatric disorders, or 
investigated for the effects of demographic variables (e.g. age, race).  
F: Feasibility 
F1: Missing values: No information  
F2: Ease of administration/burden: Time needed for completion, reading 
and/or comprehension level, special requirements or requests made of 
respondent, evidence that instrument places no undue physical or 
emotional strain on respondent 
F3: Value: for health professionals (e.g. psychologist, , psychiatrist, for 
persons with IDD, for caregiver (direct-care staff, family carer) 
F4: Acceptability: for health professional (e.g. psychologist, psychiatrist) 
F5: Availability: Available for free, can be requested from author  
Summary of Findings 
Reading and comprehension level for the respondent is minimal and no 
special requirements or requests are made of them. The instrument 
places no undue physical or emotional strain on the respondent. The 
ABDQ is user friendly and takes approximately 10-15 minutes to 
complete. The ABDQ has been developed from over 10 years of research 
investigating changes in adaptive behaviour in adults with Down 
syndrome. The tool can be considered an acceptable F for use by health 
professionals for dementia screening. A copy of the ABDQ can be obtained 
from V.Prasher (vprasher@compuserve.com) 






Sample Size Breakdown of Scores 
(yes=2, partial=1, no=0) 
by Criteria Number (C) 
Qualsyst Final Summary 
Score 
 
Dementia Questionnaire for Persons with Intellectual Disability (DLD) 
 
Evenhuis et al (1984) 
 
Single completion n=98 C1 - 2                   C8 - n/a 
C2 - 1                   C9 -  2 
C3 - 1                   C10 - 0 
C4 - 2                   C11 - 0 
C5 - n/a                C12 - 0 
C6 - n/a                C13 - 0                     
C7 - n/a                C14 - 0 
0.28 
 
Kengen et al (1987) 
 
Single completion n=271 C1 - 2                   C8 - n/a 
C2 - 1                   C9 - 2 
C3 - 0                   C10 - 2 
C4 - 2                   C11 - 0 
C5 - n/a                C12 - 0 
C6 - n/a                C13 - 1                      
C7 - n/a                C14 -1  
0.39 







n=17 C1 - 1                   C8 - 1 
C2 - 1                   C9 - 1 
C3 - 1                   C10 - 1 
C4 - 2                   C11 -
n/a 






C6 - n/a                C13 -2                      
C7 - n/a                C14 -2 
Evenhuis et al (1992) 
 
Longitudinal n=139 C1 - 2                   C8 - n/a 
C2 - 1                   C9 - 2 
C3 - 2                   C10 - 2 
C4 - 2                   C11 - 1 
C5 - n/a                C12 - 1 
C6 - n/a                C13 - 1                      




Longitudinal n=33 C1 - 2                   C8 - n/a 
C2 - 1                   C9 - 1 
C3 -1                    C10 - 0 
C4 -2                    C11 - 0 
C5 - n/a                C12 -0 
C6 - n/a                C13 - 2                      
C7 -n/a                 C14 - 0 
0.32 
Thompson et al (1994) 
 
Longitudinal n=8 C1 - 2                   C8 - n/a 
C2 - 1                   C9 - 0 
C3 - 1                   C10 - 0 
C4 - 2                   C11 - 0 
C5 - n/a                C12 - 0 
C6 - n/a                C13 - 0                     




Longitudinal n=100 C1 - 0                   C8 - 0 
C2 - 0                   C9 - 2 
C3 - 0                   C10 - 2 
C4 - 0                   C11 - 2 
C5 - n/a                C12 - 2 
C6 - n/a                C13 - 2                     
C7 - n/a                C14 - 2 
0.42 
Deb and Braganza (1999) 
 
Single completion n=62 C1 - 0                    C8 - 0 
C2 - 0                    C9 - 1 
0.35 
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C3 - 0                    C10 - 2 
C4 - 2                    C11 - 0 
C5 - n/a                 C12 - 1 
C6 - n/a                 C13 - 2                      
C7 - n/a                 C14 - 2 
Hoekman and Maaskant 
(2002) 
 
Single completion n=329 C1 - 2                   C8 - 2 
C2 - 2                   C9 - 2 
C3 - 2                   C10 - 2 
C4 - 2                   C11 - 2 
C5 - n/a                C12 - 0 
C6 - 0                   C13 - 2                      
C7 - n/a                C14 - 2 
0.71 
Silverman et al (2004).  
 
Single completion n=273 C1. 2                    C8. 2 
C2. 2                    C9. 2 
C3. 2                    C10. 2 
C4. 2                    C11. 2 
C5. n/a                 C12. 0 
C6. 0                    C13. 2                      
C7. n/a                 C14. 2 
0.71 
Strydom et al (2004) 
 
Single completion n=23 C1 - 2                   C8 - n/a 
C2 - 2                   C9 - 1 
C3 - 2                   C10 - 0 
C4 - 2                   C11 - 0 
C5 - n/a                C12 - 1 
C6 - n/a                C13 - 0                      
C7 - n/a                C14 - 1 
0.39 
Jamieson-Craig et al 
(2010) 
 
Longitudinal n=154 C1 - 2                    C8 - 0 
C2 - 2                    C9 - 2 
C3 - 2                    C10 - 1 
C4 - 2                    C11 - 2 
C5 - n/a                 C12 - 1 
C6 - 2                    C13 - 2                      
0.71 
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C7 - n/a                 C14 - 2 
McCarron et al (2014) 
 
Longitudinal n=77 C1 - 2                    C8 - 
n/a 
C2 - 2                    C9 - 1 
C3 - 2                    C10 - 2 
C4 - 1                    C11 - 2 
C5 - n/a                 C12 - 0 
C6 - n/a                 C13 - 2                     
C7 - n/a                 C14 -2 
0.57  
 
Dementia Scale for Down Syndrome (DSDS) 
 
DSDS (original manual) 
 
Longitudinal n=70 C1 - 2                    C8 - 
n/a 
C2 - 1                    C9 - 1 
C3 - 1                    C10 - 1 
C4 - 2                    C11 - 0 
C5 - n/a                 C12 - 1 
C6 - n/a                 C13 - 1                      
C7 - n/a                 C14 - 1 
0.39 
Deb and Braganza (1999) 
 
Single completion n=62 C1. 0                     C8 - 0 
C2. 0                     C9 - 1 
C3. 0                     C10 - 2 
C4. 2                     C11 - 0 
C5. n/a                  C12 - 1 
C6. n/a                  C13 - 2                      
C7. n/a                  C14 - 2 
0.35 
 
Adaptive Behaviour Dementia Questionnaire (ABDQ) 
 
Prasher et al (2004) 
 
Longitudinal n=150 C1 - 2                    C8 - 1 




C3 - 1                    C10 - 1 
C4 - 2                    C11 - 1 
C5 - n/a                 C12 - 0 
C6 - n/a                 C13 - 2                      







Dementia Screening Questionnaire for Individuals with Intellectual Disabilities (DSQIID) 
 
Deb et al  (2007a) 
 
Longitudinal n=193 C1 - 2                   C8 - n/a 
C2 - 2                   C9 - 2 
C3 - 2                   C10 - 2 
C4 - 2                   C11 - 2 
C5 - n/a                C12 - 2 
C6 - n/a                C13 - 0                       
C7 - n/a                C14 - 2 
0.64 







This review aimed to examine the characteristics and psychometric properties of four 
observer rated dementia screening tools that are recommended for assessing dementia in ID 
by the (BPS/RCP, 2009).  The review is based on Zeilinger et al.’s (2013a) recommendation 
that an examination of the available dementia screening tools be completed. A sample of the 
114 instruments they identified has been reviewed here, going some way towards extending 
the literature in this domain. Examining the characteristics and psychometric properties of 
these tools allows for a direct comparison and highlights both the strengths and limitations of 
the screening tools included. The use of the CAPS-IDD (Zeilinger et al, 2013b) and the 
Qualsyst (Kmet et al, 2004) in combination, makes it more likely that the findings of this 
review are robust.  
 
4.1 Comparison of Screening Tools: Characteristics and Psychometric Properties 
 
The studies used to evidence the CAPS-IDD ratings of the four dementia screening tools 
varied in quality. The range of quality ratings overall was 0.28-0.71 and these results are 
summarised in table 5. A clear limitation of the available literature however was the 
high proportion ( 37.5%) of the included studies that either validated or used the dementia 
screening tools at a single time point. This is contrary to the current accepted standard of 
administration in assessment of dementia which involves longitudinal assessment over at 
least two time-points (Evenhuis, 2007). This has implications for how much weight can be 
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assigned to the conclusions drawn from these studies in particular.   
 
Of the four dementia screening tools, the DLD (Evenhuis, et al, 2007) had the largest 
evidence base. In total, 13 studies were identified which were either related to its 
development or it had been used within later studies which reported further useful 
information in relation to psychometric properties. Six of these studies were based on data 
gathered from single completion. Qualsyst ratings of the studies used to evidence this 
screening tool ranged from 0.28 to 0.71. In considering the particular strengths of the DLD, it 
has been shown to be useful to achieve a diagnosis of dementia over time. However, it is 
important to be aware that the provisional criteria were based on a single completion study 
(Evenhuis et al, 1984). The author therefore commented in the updated and amended manual 
(Evenhuis, 2007) that these criteria may have led to unreliable results. Later studies were 
longitudinal in design allowing for change score criteria to be developed which make the 
current scoring of the DLD more reliable. The application of these criteria resulted in a 
sensitivity of 100%  and a specificity of 73% for the group of adults with IDD and a 
sensitivity of 100% and a specificity of 75% for the group of adults with IDD and Down 
syndrome.  Specificity ratings indicate that 27% and 25% of the respective groups would be 
incorrectly thought to have dementia when using the DLD (false positive). At approximately 
1 in 4 this remains a rather high figure and highlights the importance of robust procedures to 
identify possible differential diagnoses. However, it is important to note that in dementia 
screening it is a better outcome clinically to identify cases of possible dementia than miss 
them entirely. In a longitudinal study Prasher et al (1997) reported much lower sensitivity 
(60%) and a specificity of (67%) prompting their proposal that a higher cut-off score be used. 
Interrater reliability figures for the DLD varied between the individual subscales, with speech 
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(Pearson’s correlation = 0.68) and behavioural disturbance (Pearson’s correlation=0.44)  
subscales low compared to the others. As the CAPS IDD summary findings table for the 
DLD highlights, the main underlying theory behind the DLD is behavioural (item T1) and 
content includes problem behaviour and adaptive behaviour (item C1). Given this, it is of 
some concern that a higher level of agreement is not reached between raters on the 
behavioural disturbance subscale particularly. While the DLD appears to have some practical 
utility, there remain questions regarding its accuracy in screening for dementia. 
 
The DSDS was specifically developed for use within the lower ranges of IDD and was 
standardised on a population with Down syndrome in the severe and profound range of IDD. 
The manual (Gedye, 1995) contains an amendment added January 2007 which highlights that 
that the tool may or may not be useful for people with intellectual disability in the lower 
ranges of functioning and note that this may be confirmed by appropriate studies. However, 
there has only been one further study using the DSDS which met this review’s inclusion 
criteria.  In a sample of patients with mild, moderate and severe ID, Deb and Braganza (1999) 
reported a specificity of 0.89 and a sensitivity of 0.85. Broadly, this would mean that the 
likelihood of a false positive diagnosis using the DSDS is 15%, suggesting that it may be a 
more accurate tool than the DLD. However, this was a single completion study. The interrater 
reliability for the DSDS yielded a kappa coefficient of 0.81 (Gedye, 1995). The author of the 
tool reported on construct related validity stating that half of the sample studied progressed 
from varying levels of cognitive ability to be unable to perform tasks required  memory, 
comprehension or language. All of these people (100%) had earlier met the DSDS criterion 
for onset of cognitive decline and progression to middle and late stage dementia. The DSDS 
has not been published in a peer reviewed journal (BPS, 2009). Overall, the evidence 
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concerning the DSDS is limited. In addition, the Qualsyst ratings of the two studies related to 
this tool were relatively low at 0.39 and 0.35 respectively. Further research would likely yield 
useful data with which to identify component parts of the DSDS that could facilitate greater 
accuracy in dementia screening in the future.  
 
Only one paper relating to the DSQIID met the inclusion criteria of this review. The DSQIID 
is an observer rated dementia screening tool and the authors suggest it can be used Deb et al 
(2007) used for all adults with IDD irrespective or the level of IDD (Deb et al, 2007a). The 
study used a longitudinal design and was rated as 0.6 on the Qualsyst. This was one of the 
highest rated papers included within this review.  As the CAPS-IDD summary findings table 
for the DSQIDD highlights, the authors of the DSQIID explicitly state that the Likert scale 
scoring  system was deliberately adopted to measure changes in behaviour in an attempt to 
reduce the likelihood of the floor effects observed in tools which score current behaviour 
only. A receiver operating curve analysis was used on the data and an overall cut-off score of 
20 provided a sensitivity of 0.92 and a specificity of 0.97. This also yielded a positive 
likelihood ratio of 31 and a negative likelihood ratio of 0.08. Furthermore a forced four factor 
analysis related to only part 2 of the tool accounted for 57% of the variance. Cronbach’s 
alpha for all 53 items on the DSQIID was 0.91 showing a high level of reliability while the 
intraclass correlation for test-retest reliability was 0.95. Overall the evidence for the DSQIID 
suggests that it is a useful and accurate tool to use in dementia screening. The study used is of 
a high quality and data was gathered longitudinally. However, further studies which confirm 
these results would allow for greater confidence in the reliability of this tool.  
 
The final tool reviewed was the ABDQ. One study met the inclusion criteria was rated 0.53 
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on the Qualsyst (Kmet et al, 2004). This is a tool specifically developed to screen for 
dementia in Alzheimers disease (DAD). The authors state the ABDQ can be used for adults 
with IDD in the mild-moderate and severe-profound ranges of intellectual functioning 
(Prasher et al, 2004). Using a cut-off score of greater than 78 as indicative of a possible 
dementia, sensitivity was reported as 0.89 and specificity at 0.94.The overall percentage of 
correct identification of dementia in AD and non dementia in AD was 92%. Split half validity 
was then used to examine the data using amended weightings on particular items, giving a 
comparable accuracy of 94%.  Prasher et al (2004) reports interrater reliability of 0.954. As 
with the other tools, given the dearth of literature and exploratory studies which investigate 
the psychometric properties of the ABDQ, further research is required to verify the current 
findings.  
 
Overall the largest evidence base was found for the DLD, though some of the evidence 
identified was conflicting. For example, the sensitivity and specificity values varied between 
studies. In addition, some of the studies reported on only single completion rather than 
longitudinal data. Given this, and the dearth of an evidence base for the remaining three tools, 
it is difficult to draw any definitive conclusions about the predictive accuracy of each tool 
relative to each other. Nevertheless, based on the evidence presented within the CAPS IDD 
schedules, the most practical tools to use appeared to be the DLD and the ABDQ due in part 
to the simplicity of administration. The DSQIID and the DSDS have a more complex 
structure and therefore process for administration. Despite the practicality of both the DLD 
and the ABDQ, in the case of the ABDQ, the evidence base was limited to a single paper. 
Further scrutiny of tools with such limited evidence is required to ascertain with greater 
accuracy their ability to detect dementia in people with intellectual disabilities. Therefore the 
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current review would suggest that the DLD has the greatest evidence base to support its use 
as a screening tool within this population, though caution must be exercised given the 
conflicting nature of some of the evidence presented.  
 
4.3 Strengths and Limitations of Current Review 
The present review has reviewed a sample of the dementia screening tools available for 
people with a learning disability.  The methodology of this review was based on a previous 
review by Zeilinger et al (2013). While this provided a solid foundation on which to base the 
current review, the use of the CAPS-IDD, which itself was developed by Zeilinger, as a 
method of structuring the information has posed some key challenges. While it provided a 
thorough and relatively easy to collate schedule of the evidence identified, this was countered 
by its high level of detail required and on occasion repetition. For example, some evidence 
was presented twice, due to lack of clarity regarding which section was the ‘best fit’.  This 
has resulted in the evidence presented in section 3.2 in tables 1-4 being somewhat difficult to 
summarise. In particular it can be difficult to ascertain which are the most salient pieces of 
information. This tool has only recently been developed and there are currently no published 
studies which have used it for the purposes of research or reviewing a particular tool. The 
Qualsyst, while a useful tool allowing for a numerical comparison across studies, is potentially 
susceptible to bias. This is largely as a result of it being a subjective view of the authors’ 
perceptions of the key components of study design which they acknowledge (Kmet et al, 2004). 
A further key limitation of the study is the search strategies narrow focus on four specific tools. 
A broader approach, perhaps including a greater number of tools used currently in clinical 
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practice would allow for a greater degree of scrutiny and comparison. However, it was 
pragmatic to examine those tools most likely to be frequently used within UK clinical 
psychology settings for the purposes of dementia assessment. The four tools therefore included 
within the review were selected due to their inclusion in the BPS guidance document Dementia 
and People with Intellectual Disabilities (2009). BPS guidance notes that these tools can be 
considered as best practice (BPS, 2009). Despite this, the current review highlights the lack of 
an evidence base for all tools except the DLD. This calls into question the validity of such tools 
within clinical practice and perhaps even whether these can indeed be considered as best 
practice when screening for dementia. It may be more accurate to say that these tools can be 
considered as best practice when compared to clinical judgment alone or the absence of 
screening altogether.  
 
5. Conclusions 
This systematic review has provided a useful comparison of four commonly used UK   
dementia screening tools for people with intellectual disabilities. The evidence base for the 
four dementia screening tools remains limited. There is also a clear requirement for 
clinicians, working in intellectual disabilities services to complete further validation 
studies to facilitate greater understanding of the  psychometric properties and accuracy of the 
tools. Ideally such studies would be prospective, and attempt to address the question of which 
parts or individual items of the existing tools might helpfully be combined to increase the 
utility and accuracy of dementia screening in this population. Although a substantive 
undertaking, such work would be an invaluable contribution toward the development of more 
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accurate screening tools for people with dementia and ID.  
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AIMS AND HYPOTHESES 
This thesis was an exploratory study. It aimed to investigate patterns in cognitive and social 
functioning over time in a population of adults with intellectual disability and Down 
syndrome using data from the Adaptive Behaviour Dementia Questionnaire (ABDQ;  
(Prasher et al, 2004) and the Dementia Questionnaire for People with Learning Disability 
(DLD; Evenhuis et al, 2007), formerly known as the Dementia Questionnaire for Persons 
with Mental Retardation (DMR; Evenhuis et al, 1996). Longitudinal data were examined 
to ascertain whether the domains covered in these identify differences between those 
individuals who do develop dementia and those who do not in this population.  
 
The research also aimed to further examine the data to discern whether particular subscales of 
the DLD are more predictive of dementia than others. A further aim of the research was to 
compare the dementia screening tools to identify whether one tool, individual sub-scales or a 
combination of both tools is better able to distinguish between the dementia and no dementia 
group. Essentially, the study sought to identify whether the data would highlight an 
observable pattern that distinguishes between normal and abnormal ageing in this population. 
It was hypothesised that: 
1) The mean ABDQ total score will be higher in those who are later diagnosed with 
dementia. 
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2) The mean DLD total and sub-scale scores will be higher in those who are later 
diagnosed with dementia.  
3) The Sum of Cognitive Scores and individual components of this sub-scale (Short-term 
memory, Long-term memory, Spatial and Temporal Orientation) will be higher in those 
who are later diagnosed with dementia.  
4) The Sum of Cognitive Scores and /or individual components of this sub-scale (Short-
term memory, Long-term memory, Spatial and Temporal Orientation) will more 
accurately distinguish between the dementia and no dementia groups than total DLD 
score alone.   
5) The ‘Sum of Social Scores’ or an individual component of this sub-scale (Speech, 
Practical Skills, Mood, Activity and Interest and Behavioural Disturbance) of the DLD 
will more accurately distinguish between the dementia and no dementia groups than 
total DLD score alone.  
6) An observable pattern will be present which would determine more accurately the onset 












The second part of this thesis is a piece of empirical research presented in a journal article style. 
It is formatted for submission to the Journal of Applied Research in Intellectual Disabilities 
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Background:  A population sample of people with Down syndrome and intellectual disability have been studied 
longitudinally. Data was gathered from their attendance at local health screening clinics for people with Down 
syndrome and intellectual disability. They study was exploratory, investigating the differences between normal 
and abnormal ageing in this population.  
Materials and Method:  Total scores on the Adaptive Behaviour Dementia Questionnaire (ABDQ) and total and 
sub-scale scores the Dementia Questionnaire for Learning Disability (DLD, formerly the DMR) were collated. 
Data were examined to identify whether these tools were able to accurately distinguish between those who 
develop dementia and those who do not. Patterns of change were also examined between groups in order to 
identify whether the tools or individual subscales of the tools were able to distinguish between normal and 
abnormal ageing.  
Results: Results were mixed. Visual inspection of the ABDQ and DLD scores over time showed a clear pattern 
of more rapidly increasing scores over time in the dementia group compared with the no dementia group. This 
would suggest that the tools accurately distinguish between the two groups. However, the MANOVA conducted 
did not reach statistical significance, suggesting either that the study was underpowered, or that the effect was 
not, in actuality, present. A series of ROC analyses suggested that the ABDQ had poor to fair predictive quality 
and the DLD worthless to fair predictive quality in identifying dementia in the population sampled.  
Conclusion: Given the results, it is difficult to draw any definitive conclusions regarding the predictive accuracy 
of either the ABDQ or the DLD. Further prospective analysis is required utilising a larger sample size. 




Down syndrome is the most common genetic cause of mild and severe intellectual disability 
(Minns, 1997, Coppus et al, 2006) and people with intellectual disabilities (ID) are at increased 
risk of developing Alzheimer’s type dementia (Jervis and Prinsloo, 2007). It is well-established 
that those with Down syndrome (DS) are more likely to develop Alzheimer’s type dementia 
earlier in their life than those with intellectual disability alone (Bush et al, 2004; McBrien, 
2005; Visser, 1997). Depressive illness, hypothyroidism and visual/hearing impairments are 
also more common in people with Down syndrome and can, in some cases, present much like 
dementia (Quality Improvement Scotland, 2006, British Psychological Society, 2009), making 
diagnosis particularly challenging in this group.  
Prevalence of dementia has been estimated at 10 percent between the ages of 40-49 and 40 
percent per cent between the ages of 50-59 years in adults with Down syndrome (Holland et 
al, 1998). This is compared to an overall prevalence of 7.2% dementia in the general adult 
population over 65 (Galeotti et al, 2013). Despite additional health issues and as a result of 
improved health care and knowledge, the average life expectancy of people with Down 
syndrome has increased to 50 years of age, with 20 percent of people living beyond 55 years 
(Holland, 1999).  It is predicted that by the year 2020 the proportion of all people over 65 with 
intellectual disability will have doubled (Janicki and Dalton, 2000). Bolstered by policy drivers 
such as the Government’s White paper ‘Valuing People’ (Department of Health, 2001), there 
has been a clear shift within healthcare to consider the holistic health needs in those with 
intellectual disabilities and Down syndrome in efforts to tackle a growing health divide. 
Prospective health screening of this group has become embedded in good clinical practice and 
the benefits of this are well documented in the literature (Webb and Rodgers, 1999; Barr et al, 
1999). 
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While there are established screening tools designed to assess for dementia in the general adult 
population, the same cannot be said within the intellectual disability population. In a recent 
study, Zeilinger et al (2013a) reviewed all assessment instruments used to screen for dementia 
in people with a intellectual disability. It was noted that a number of assessments being used 
in clinical practice were not originally developed either for people with intellectual disability, 
or for assessing for the presence of dementia. Pre-existing cognitive impairments further 
complicate the diagnostic process for those with intellectual disabilities with some pointing 
towards discrepancies in research in this area a function of this difficulty (Silverman et al, 
2013). There is a clear requirement therefore to establish a consistent procedure for dementia 
screening for people with intellectual disabilities (Matson and Boisjoli, 2009). Zeilinger et al 
(20013a) recommended using only those tests developed or adapted specifically for individuals 
with intellectual disability within their review. A key limitation of the review was that it did 
not evaluate the psychometric properties of the tools, instead making this a recommendation 
for further research. The current paper adds to the existing literature by beginning the lengthy 
process of evaluating tools currently used in clinical practice.  
1.1 Screening Tools 
The screening tools within this study are the Adaptive Behaviour Dementia Questionnaire 
(ABDQ) (Prasher et al, 2009) and the Dementia Questionnaire for People with a Learning 
Disability, (DLD) (Evenhuis, 2007) formerly known as the Dementia Questionnaire for 
Persons with Mental Retardation (Evenhuis, 1996). These screening tools are two of those 
recommended by the BPS guidance document ‘Dementia and People with Intellectual 
Disabilities’. A recent review by Zeilinger et al., (2013) recommended that all dementia 
screening tools are evaluating to identify which are more accurate in correctly identifying 
dementia in this population.  
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The ABDQ is a 15-item questionnaire designed to detect change in adaptive behavior. It was 
developed from an earlier screening tool known as the AAMD Adaptive Behaviour Scale 
(Nihira et al, 1974) and was intended specifically for screening for dementia in Alzheimers 
disease. It compares a person’s current presentation compared to previous level of social 
functioning. The tool provides cut-offs for dementia and a rating on severity as follows: mild 
– ≥ 78-89, moderate – ≥ 90-99, severe - ≥100). The possible score range on the ABDQ is 0-
111. The tool has been shown to have good reliability, validity and an overall accuracy of 92% 
(Prasher et al, 2004). The ABDQ instructs that it should be completed by a caregiver or family 
member who knows the patient well and has worked or lived with them consistently over time 
or an experienced clinician.  
 
The DLD is a 50-item carer completed questionnaire divided into eight sub-categories. Three 
of these sub-categories (Short-term memory, Long-term memory and Orientation) make up the 
‘Sum of Cognitive Scores’. The remaining five (Speech, Practical skills, Mood, Activity and 
Interest and Behavioural disturbance) the ‘Sum of Social Scores’. Combining ‘Sum of 
Cognitive Scores’ and ‘Sum of Social Scores’ gives the total raw score. The original DMR 
manual highlights that the cornerstone of diagnosing dementia in people with intellectual 
disability is a decline in functioning over time (Evenhuis, 1995). The researcher noted that this 
has important implications for clinical practice, as the tool was anticipated to be most sensitive 
when used repeatedly, allowing for comparison between assessment points longitudinally, 
independent of pre-morbid function. Essentially, change score is fundamental to overall 
diagnostic utility rather than absolute score at one time point.  The guidance paper, Dementia 
and People with Learning Disabilities’ (British Psychological Society, 2009) notes that the 
DLD is widely used throughout the UK and Europe to screen for the early detection of dementia 
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in people with intellectual disabilities. Evenhuis (1992, 1996), found that the DLD had a 
sensitivity level of up to 100% in identifying dementia and provided both change scores and 
cut-offs likely to indicate dementia. A specificity of 73% was reported in an elderly intellectual 
disabilities sub-group and 75% in a Down syndrome sub-group. This was independent of pre-
morbid intellectual functioning. However, it has been reported previously that the DLD has 
poor inter-rater reliability (Evenhuis, 1996). Another key difficulty with the tool in clinical 
practice is accurately determining the level of intellectual disability of the patient. This is likely 
a contributory factor to its lack of reliability between raters. Despite the earlier assertions 
within the manual that the tool is most sensitive when used longitudinally, suggestions have 
been made previously regarding modifying cut-offs to ameliorate relatively low longitudinal 
sensitivity from 60% to 82% (Prasher, 1997).  
 
In line with Zeilinger et al.’s (2013) recommendation that all dementia screening tools be 
further evaluated, this evaluated two tools recommended in the most recent BPS (2009) 
guidelines ‘Dementia and People with Intellectual Disabilities’. Specifically, this exploratory 
study intended to identify whether the tools accurately differentiate between two groups; those 
who develop dementia and those who do not. It is also intended to identify any pattern of age 
related change between those who develop dementia and those who do not.  
 
1.2 Local Procedure 
The data to be examined within the study was collected at a Down Syndrome Health Screening 
Clinic. Data is collected annually until such time as the patient receives a diagnosis of dementia. 
Assessment involves a comprehensive, multi-disciplinary process which also involves 
screening for any physical health conditions that may give rise to symptoms similar to those 
observed in dementia (e.g. hypothyroidism). A multi-disciplinary consensus is reached with 
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regard to whether the patient requires further diagnostic assessment.  
 
The following exploratory study aimed to investigate whether differences could be found in 
patterns of responses in adults with Down Syndrome who develop dementia and those who do 
not and the predictive accuracy of two dementia screening measures. These were the Adaptive 
Behaviour Dementia Questionnaire (ABDQ; Prasher et al, 2004) and the Dementia 
Questionnaire for People with a Learning Disability (DLD; Evenhuis et al, 2007). The research 
questions were; 1) Is there a particular sub-scale of the DLD that is more predictive of dementia 
that others? 2) Is the ABDQ or the DLD better able to distinguish between the ‘dementia’ and 
‘no dementia’ group 3) Is there an observable pattern of responding which distinguished 
between normal and abnormal ageing in this population.  
 
2. Method  
2.1 Participants 
The participants were patients who had attended the Down Syndrome Health Screening 
Clinics with their carer or family member acting as informant to complete the ABDQ or the 
DLD. All participants had an intellectual disability and Down syndrome. An attempt was 
made to obtain IQ data , but this was unavailable for the majority of the data set and was 
therefore not included in the analysis. Education level and living arrangements of participants 
was also unavailable. The primary data set consisted of 64 participants selected from a 
possible total of approximately 130 participants who had attended the Down Syndrome 
Health Screening Clinic. Participant files used were those that were available i.e. identified by 
the database administrators and sent to be reviewed by the researcher. The remaining 
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participants’ data was not collected due to the substantial time and resource that this would 
have required.  
 
As the primary data set consisted of retrospective clinical data, it was not possible for 
participants to be age-matched in the way that might have been possible with a prospective 
study. Therefore a secondary data set, specifically selected from within the primary data set 
consisted of an age-matched group of 22 participants. This controlled for age as a 
confounding variable i.e. subsequent analysis would identify any differences in results which 
could have been due to a non age matched sample in the primary data set.  
 
Half of the participants (n=32) from within the full data set had previously been diagnosed 
with dementia, forming the ‘dementia’ group to be compared against the ‘no dementia’ 
group. Diagnosis for these individuals followed the best practice guideline Dementia and 
People with Intellectual Disabilities: Guidance on the assessment, diagnosis, interventions 
and support of people with intellectual disabilities who develop dementia (BPS, 2009). 
Essentially, diagnosis was made following a multi-disciplinary team assessment, collating 
information from various professions including psychology, psychiatry, nursing occupational 
therapy, and speech and language therapy. The multi-disciplinary teams which made a 
diagnosis in these cases follow this ‘gold standard’ guidance which also states that ‘the 
clinical or other qualified psychologist and psychiatrist will be the key disciplines involved in 
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reviewing the outcome of multidisciplinary assessment and then arriving at a diagnosis, with 
support from the multidisciplinary team’ (BPS, 2009).  
 
2.2 Data Collection  
Psychology records for each patient attending the DSHSC between 2005 and 2015 were 
reviewed retrospectively and relevant data retrieved. No patient contact was required. All 
available pre-existing total scores on the Adaptive Behaviour Dementia Questionnaire 
(ABDQ) and total and sub-scores on the Dementia Questionnaire for people with Learning 
Disabilities (DLD) were collated. The data recording sheet included sections for demographic 
data such as gender and age as well raw scores and other relevant information. This section 
also included a participant number. This unique number was linked to patient names to ensure 
the data could be traced back to patient files if required. Names of patients, required as the key 
to participant numbers were kept separately and securely in accordance with data protection 
and Caldicott guardian guidelines. The data had been collected previously as part of routine 
clinical practice. Caldicott Guardian approval to access the data was sought and granted (see 
Appendix 4). The project was registered with the local NHS Research and Development 
Service and NHS Clinical Governance team as required by local research protocol and 
guidelines.  
 
2.3 Data Analysis Strategy 
Analyses were conducted using IBM SPSS Statistics (2015). Though longitudinal data across 
approximately twelve time points was collected, the three data points from baseline(BL), 
time-point 1(TP1) and time-point (TP2) two were selected for analysis as this ensured that 
90.6% of participants were included (i.e. 90.6% of the   participants in the data set has 
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completed the measures across BL, TP1 and TP2).  The period of time between BL to TP1 
and TP1 to TP2 was approximately 1 year, therefore the data analysed was across a two year 
period. Mean scores at BL, TP1 and TP2 were calculated for ABDQ total score, DLD total 
score, Sum of Cognitive Scores (SCS), Sum of Social Scores (SOS) and the individual 
component parts of these subscales; Short-term memory (STM), Long-term memory (LTM), 
Spatial and temporal orientation (STO), Speech (SP), Practical Skills (PS), Mood (M), 
Activity and Interest (AI), Behavioural Disturbance (BD).  Analysis was conducted across 
the primary data-set (n=64) and a secondary age matched data-set (n=22). A repeated 
measures MANOVA was conducted to test the differences between the two groups; those 
who were later diagnosed with dementia and those who were not over time. Finally, a series 
of receiver operating characteristics (ROC) curve analyses were conducted to determine the  




The use of three time points across a two year period ensured that 90.6% of the participants 
within the full data-set and 100% of the participants within the age-matched data set were 
included within the analysis (see Table 1). At TP3, only 48 of the 64 participants in the full 
data set had useable data (75%) and this was therefore chosen as the cut-off. In the age 
matched data set 100% of the participants had useable data at TP2.  
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The primary data set consisted of 64 participants; 32 participants within both the ‘dementia’ 
and ‘no dementia’ groups. The age range within this group was 42-74 years with a mean age 
of 57.25. Of the 64 participants, 30 were male with a mean age of 59 years and 34 were 
female with a mean age of 56 years. The secondary data set consisted of an age-matched 
group of 22 participants; 11 participants within both the ‘dementia’ and ‘no dementia’ 
groups. The age range within this group was 47-64 years with a mean age of 55.18. Of the 22 
participants, 7 were male with a mean age of 54.57 and 15 were female with a mean age of 
55.47.   
 
Table 1. Percentage of participant data by time-point 
 Full data set (n=64) Age matched data-set (n=22) 
Time-point Number of participants 
(n) 




Percentage of all 
participants (%) 
Baseline (BL) 64 100% 22 100% 
Time-point 1(TP1) 62 96.9% 22 100% 
Time- point 2(TP2) 58 90.6% 22 100% 
Time-point 3(TP3) 48 75% 20 90.9% 
 
3.1 ABDQ Main Results 
As shown in Table 2, total ABDQ scores over time show that the tool accurately differentiates 
between those who receive a diagnosis of dementia and those who do not. As hypothesised, 
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overall scores in both the full and age-matched data sets for the ‘dementia’ group are higher at 
all three time-points. In the full data set at baseline, the mean total score in the ‘no dementia’ 
group was 37.6 compared to the ‘dementia’ group mean of 44.8. There is then an increase in 
the mean total score in the ‘dementia’ group from 44.8 to 52.1, an increase of approximately 7 
points. In comparison the mean total score in the ‘no dementia’ group increases from 37.6 to 
40.7, an increase of only 3 points.  Figures 1 shows the scores for the ‘dementia’ and ‘no 
dementia’ group in the full data set over time.  
Table 2. Mean total scores ABDQ by group 
 Full data set (n=64) Age matched data set (n=22) 
Time-point No Dementia Dementia No Dementia Dementia 
Baseline (BL) 37.6 44.8 42.7 45.6 
Time-point 1(TP1) 40.7 52.1 43.8 55.3 


















Figure 1. Mean ABDQ total scores over time (full data set)  
 
In the age-matched data set at baseline, the mean total score in the ‘no dementia’ group was 
42.7 compared to the ‘dementia’ group mean of 45.6. There is then an increase in the mean 
total score in the ‘dementia’ group from 45.6 to 65.3, an increase of approximately 20 points. 
In comparison the mean total score in the ‘no dementia’ group increases from 42.7 to 45.2, an 
increase of only 3 points approximately. The age-matched data set demonstrates a more 
pronounced pattern of increasing scores over time (see Figure 2).  
 
Figure 2. Mean ABDQ total scores over time (age-matched data set) 
 
3.2 DLD Main Results 
Total DLD scores over time also demonstrate that the tool differentiates between those who 













Table 3. Mean total score DLD by group  
 Full data set (n=64) Age matched data set (n=22) 
Time-point No Dementia Dementia No Dementia Dementia 
Baseline (BL) 31.3 32.2 29.4 29.5 
Time-point 1(TP1) 33.5 37.0 27.2 36.2 
Time-point 2(TP2) 34.8 43.9 28.5 47.6 
 
 
As hypothesised, overall scores in both the full data set and the age matched data set in 
‘dementia’ group were higher at all three time-points. At baseline the mean total score in the 
‘no dementia’ group in the full data set was 31.3. This was relatively similar in the ‘dementia’ 
group where the baseline mean was 32.2. Overall across the three time-points, there is a 3 point 
increase in the mean total score in the ‘no dementia’ group from 31.3 to 34.8, compared to an 
11 point increase in the ‘no dementia’ group the mean total score increases from 32.2 to 43.9.  
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Figure 3. Mean DLD total scores over time (full data set) 
 
 
Figure 4. Mean DLD total scores over time (age-matched data set) 
 























group was almost the same figure at 29.4 and 29.5 respectively. In the ‘dementia’ group the 
scores over time fluctuate from 29.4 at baseline, to 27.2 at TP1 and 28.5 at TP2. In comparison 
the mean total score in the ‘no dementia’ group increases from 29.5 to 47.6, an increase of 
approximately 18 points. It would appear that the age-matched data set demonstrates a more 
pronounced pattern of increasing scores over time.  
 
3.3 Sum of Cognitive Main Results 
As shown in Table 4, total SCS scores over time indicate that the tool differentiates between 
those who receive a diagnosis of dementia and those who do not. In the full data set at baseline, 
the mean total score in the ‘no dementia’ group was 17.7 compared to the ‘dementia’ group 
mean of 18.4. There is then an increase in the mean total score in the ‘dementia’ group from 
18.4 to 23.4, an increase of 6 points. In comparison the mean total score in the ‘no dementia’ 
group increases from17.7 to 19.2, an increase of under 2 points.  Figure 3. shows the scores for 
the ‘dementia’ and ‘no dementia’ group in the full data set over time. In the age-matched data 
set at baseline, the mean total score in the ‘no dementia’ group was 15.7 compared to the 
‘dementia’ group mean of 16.4. There is then an increase in the mean total score in the 
‘dementia’ group from 16.4 to 24.8, an increase of over 8 points. In comparison, the mean total 
score in the ‘no dementia’ group decreases from 15.7 at BL to 15.2 at TP2, an overall decrease 
of 0.5 points (3.2%). 
 
Table 4. Mean total score Sum of Cognitive Scores (SCS) by group 
 Full data set (n=64) Age matched data set (n=22) 
Time-point No Dementia Dementia No Dementia Dementia 
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Baseline (BL) 17.7 18.4 15.7 16.4 
Time-point 1(TP1) 18.2 20.4 15.0 19.6 





























Figure 5. Mean Sum of Cognitive Scores (SCS) over time(full data set) 
 




3.4 Sum of Social Main Results 
As shown in Table 4. total SOS scores over time suggest that the tool differentiates between 
those who receive a diagnosis of dementia and those who do not. In the full data set at baseline, 
the mean total score in the ‘no dementia’ group was 13.5 compared to the ‘dementia’ group 
mean of 13.7. There is then an increase in the mean total score in the ‘dementia’ group from 
13.7 to 20.5, an increase of just under 7 points. In comparison the mean total score in the ‘no 
dementia’ group increases from 13.5 to 15.6, an increase of just over 2 points.  Figure 5. shows 
the scores for the ‘dementia’ and ‘no dementia’ group in the full data set over time. In the age-














compared to the ‘dementia’ group mean of 13.2. There is then an increase in the mean total 
score in the ‘dementia’ group from 13.2 to 23.3, an increase of over 10 points. In comparison, 
the mean total score in the ‘no dementia’ group increases from 13.7 at BL to 13.4 at TP2, an 
overall decrease of 0.3 points (0.3%). 
 
Table 5. Mean total score of Sum of Social Scores (SOS) by group 
 Full data set (n=64) Age matched data set (n=22) 
Time-point No Dementia Dementia No Dementia Dementia 
Baseline (BL) 13.5 13.7 13.7 13.2 
Time-point 1(TP1) 15.3 16.5 12.2 16.7 
Time-point 2(TP2) 15.6 20.5 13.4 23.3 
 














Figure 8. Mean Sum of Social Scores (SOS) over time (age-matched data set) 
Table 6. summarises the main results across both data the full and age-matched sets with regard 
to the number of points (percentage) change from BL to TP2. Of the individual DLD domains 
the highest change was observed within ‘practical skills’. This was 42% for the full data set 
and 62.9% for the age-matched data set.  
 Full data set Age-matched data set 
 No Dementia Dementia No Dementia Dementia 
ABDQ ↑4.6 (11.4%) ↑8.6(16.2%) ↑2.5(5.6%) ↑19.7(30%) 
DLD ↑3.5(10.1%) ↑11.6(26%) ↓0.9(3.1%) ↑18.1(38.1%) 
SCS ↑1.5(7.9%) ↑5.0(21.4%) ↓0.5(3.2%) ↑8.4(33.9%) 
SOS ↑2.1(13.5%) ↑6.8(33.2%) ↓0.3(2.2%) ↑10.1(43.4%) 
STM ↑0.9(17.4%) ↑2.4(32.5%) ↑0.9(18%) ↑3.9(47%) 











STO ↑0.1(1.5%) ↑1.5(19.3%) ↓1.3(21.7%) ↑1.0(13.6%) 
SPEECH ↑0.2(8.7%) ↑1.0(35.8%) ↑0.4(21.1%) ↑1.6(43.3%) 
PRACTICAL 
SKILLS 
↑0.8(30.8%) ↑1.3(42%) ↑0.4(15.4%) ↑2.2(62.9%) 
MOOD ↓0.1(2.6%) ↑1.9(32.3%) ↓0.6(16.7%) ↑2.2(33.9%) 
ACTIVITY AND 
INTEREST 
↑1.0(27.8%) ↑1.4(33.4%) ↑0.2(5.8%) ↑2.7(53%) 
BEHAVIOURAL 
DISTURBANCE 
0(0%) ↑1.1(25%) ↓0.8(24.3) ↑1.4(30.5%) 
Table 6. Points(Percentage) change over time by group (baseline to TP2) 
 
3.5 Repeated Measures MANOVA 
A repeated measures MANOVA was conducted, for both the full and age-matched data sets, 
to test the interaction effects on dementia screening scores over time by group. For the full 
data set, the results showed that there was no significant differences between ‘dementia’ and 
‘no dementia’ groups on the ABDQ and DLD scores together over time, Pillai’s Trace =  
.041, F(2, 55) = 1.161, p <0.321. No significant differences was also observed in 
dementia screening scores over time by group in the age-matched data set, Pillai’s Trace = 
0.003, F(2, 19) = 0.27, p <0.973. Due to the results being non-significant post hoc 
testing was not indicated.  
 
3.6 Receiver Operating Characteristics (ROC) Curve Analysis  
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A series of receiver operating characteristics (ROC) curve analyses were conducted across all 
three time points for both the full and age-matched data set. With regard to the ABDQ, 
analysis of the full data set yielded an area under the curve for the ranging between 0.720 at 
time point 1 to 0.709 at time point 3.This would suggest that the test can be considered of 
‘fair’ quality when assessing for the presence of dementia in this group. In the age matched 
group the area under the curve for the ABDQ ranged from 0.628 at time point 1 to 0.748 at 
time point 3. This would suggest that the test can be considered as ‘poor – fair’ quality. With 
regard to the DLD, analysis of the full data set yielded an area under the curve for the ranging 
between 0.524 at time point 1 to 0.633 at time point 3. This would suggest that the test can be 
considered of ‘worthless to poor’ quality when assessing for the presence of dementia in the 
population sampled. In the age matched group the area under the curve for the DLD ranged 
from 0.579 at time point 1 to 0.793 at time point 3. This would suggest that the test can be 
considered as ‘poor to fair’ quality. For further information on ROC analysis and the rating 
cut-offs for the area under the ROC curve, please refer to Hanley and McNeil (1982).  
 
 Full data set Age-matched data set 

























1 2 3 1 2 3 
ABDQ  0.720 0.710 0.709 0.628 0.719 0.748 
DLD 0.524 0.572 0.633 0.579 0.698 0.793 
 Table 7. Area under the curve values for ABDQ and DLD in full and age-matched data sets 
  
In summary, the results as shown in figures 1- 8 suggest that both the ABDQ and DLD scores 
over time differentiated between those who develop dementia and those who not. It was also 
clear that there was a more pronounced effect in the age-matched data set. Despite this the 
MANOVA did not reach statistical significance, suggesting that no such pattern existed. 
ROC analysis yielded further evidence that the tools were not particularly reliable or sensitive 
in detecting dementia in the population sampled.                                                                                                                                                                                                                                                                                                                                           
 
4. Discussion 
As hypothesised, the mean total ABDQ, DLD, SCS, SOS and individual DLD domain scores, 
all differentiate between the ‘dementia’ and ‘no dementia’ groups with total scores being 
higher in the ‘dementia’ group in both the full and age-matched data sets. Overall, the 
differences between groups was more pronounced in the age-matched data set. Despite the 
clear pattern of elevated scores over a two year time period in the ‘dementia’ group 
compared to the ‘no dementia’ group, no significant interaction effects were found on 
dementia screening scores over time by group. This might in part be due to the small sample 
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size of both the full and age-matched data set. Another possibility is that the tools are not 
sensitive enough in identifying the changes associated with the onset of dementia in people 
with intellectual disabilities.  
 
4. 1 Clinical Relevance 
The findings presented here would suggest that both the ABDQ and the DLD may be useful 
tools to aid clinicians in differentiating between normal and abnormal ageing in this 
population. Furthermore, it would seem that the tools are able to highlight even at this early 
stage i.e. the period from baseline to TP2, a period of two years, an observable difference 
between the ‘dementia’ and ‘no dementia’ groups. This might suggest that prolonged 
assessment over several years is not necessarily the most cost effective or efficient way to 
monitor or assess for dementia in intellectual disability. Previously Jones et al (2009) had 
highlighted how this model of assessment could be considered resource intensive.  However, 
this assumption would have to be explored in greater depth before any meaningful 
conclusions could be drawn and the resultant change in practice. Given the nature of 
dementia assessment being longitudinal, it could be argued that the process may become 
arduous to adhere to for the patient and their carer, resulting in ‘drop outs’ from assessment. 
Jones et al (2013) acknowledged that often additional support may be required including 
transport, providing information, remembering appointments and following through with 
recommendations made and that this role often falls to inexperienced health and social care 
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staff. It may also be possible that the ‘dementia’ and ‘no dementia’ groups within this 
population are actually fundamentally different in some key domain. Exploratory factor 
analysis of the individual items and domains within dementia screening tools might be one 
way to begin to explore these differences further. The ultimate goal of this would be to aid 
the early identification of dementia within people with intellectual disability.  
 
The ROC analyses would suggest that neither the ABDQ nor the DLD were particularly 
reliable in predicting who was developing dementia in the population sampled, with ratings 
only reaching ‘fair’ quality. The increase in the area under the curve value over time may in 
fact reflect dementia symptoms becoming more obvious to the raters of the tools, rather than 
the tools becoming more accurate in predicting dementia.  
 
 
4.2 Limitations of Current Research 
One key limitation of the research presented here is the use of retrospective, longitudinal 
clinical data. While longitudinal data is highly desirable in clinical research, this has in some 
cases led to inconsistencies in the data collected, as local practice has shifted over time. For 
example, information relating to level of learning disability could not be controlled for as 
many participants had never been formally assessed. In addition, of those who had been 
assessed, the tools used to complete a cognitive assessment varied and therefore could not be 
reliably used for comparison. Information with regard to where participants were living was 
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also unavailable and may have changed over the assessment period. In the 2001 Department 
of Health Report, Valuing People it was estimated that almost two thirds of people with 
learning disabilities live with their families, 37% in communal housing (rising to 70% of 
those aged 55 or over). However a further commentary on dementia screening in a learning 
disability service noted a differing compliment where 40% of the adults with Down 
Syndrome were living with their families, 53% in residential homes for people with learning 
disabilities, 8% in supported living and 1 person living in a care home (McBrien, 2005). In a 
prospective study it may be useful to track this information to identify if dementia is 
identified earlier in a particular setting.  
 
Furthermore, given the data was collected clinically over a substantial time period, there was 
inevitably individual missing items. In these instances, missing data could not be followed up 
and rectified due to the retrospective design. A further limitation of the study is the small 
sample size which may have contributed to the non-significant interaction effects found. 
Despite these limitations the study has utilised data directly from a clinical population.  This 
is not only potentially highly informative, but conclusions drawn from such research have the 
potential to alter and define clinical practice into the future. A further limitation of the study 
was the difficulties in age matching the data. In the full data set this was not possible due to 
the retrospective design. However, having collated the data for the full data set (n=64) and 
reviewing ages, an age matched data set was selected for analysis. Inevitably this meant a 
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much smaller sample of people (n=22). Ideally, in a prospective research design, the sample 
size would have been larger than either the full or the age matched comparison data set. This 
would allow for further exploratory factor analysis. This could not be performed within this 
study as power would have been insufficient.  
 
4. 3 Recommendations for Future Research 
Continued exploratory evaluation of available data is a clearly necessary to advance the 
current knowledge around dementia screening in intellectual disability. It is recommended 
that this be conducted at both local and national levels. This would highlight possible 
variations in the data across different areas and populations but also demonstrate areas of 
consistency in the research. If the research had been a prospective study it would have been 
prudent to ensure that the number of participants included allowed sufficient power to 
conduct further exploratory factor analysis. This may have yielded further interesting results 
with regard to individual items and domains within the DLD and their ability to accurately 
identify possible dementia in this population. It is also recommended that identifying the 
level of learning disability in a consistent way would allow for further analysis with respect 
to the patterns of ageing between mild-moderate and severe-profound intellectual disability 
groups to be established.  
 
One of the challenges in conducting this research was the process of local data collection 
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itself. As participants were from three separate localities, data was stored in separate  
locations with different operating systems and databases in place for its management. This 
posed some challenges in both identifying the data in the first place, selecting the cases for 
collation and then in subsequently accessing the paper files themselves which were either 
stored in a further location or were currently open to one of a number of clinicians. In 
addition to this, the sheer volume of data to be collected was vast, given the  annual 







In conclusion, the study has demonstrated that visual inspection of ABDQ and the DLD 
scores over time showed a  pattern of increasing scores in those who develop dementia as 
compared to those who do not. However, given the non-significant results yielded by 
MANOVA and the low area under the curve values identified by ROC analysis, further 
analysis would be indicated before making any definitive conclusions. This might seek to 
incorporate an in-depth exploration of the individual component items of the tools, allowing 
us to isolate particular items, using exploratory factor analysis, which could be more 
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predictive of a later diagnosis of dementia. Prospective collection of data would also allow 
for greater ability to control for confounding variables. Increasing the sample size may also 
demonstrate a greater effect size. These conclusions are supported by Starkey et al (2014) 
who suggest it is unlikely that the subtle early signs of dementia in Down Syndrome will be 
picked up by this type of screening. They also point toward further research to evaluate 
whether current screening frequency is actually allowing us to identify dementia any earlier 
or not.  
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Appendix 1: Assessments used at DSHSC (reproduced from Jones et al, 2009)  
Appendix 2: JARID Author Guidelines   
Appendix 3: Data Recording Sheets 
























APPENDIX 1: Assessments used at Down Syndrome Health Screening Clinic 
Station  Professional Assessment Carried out 
A Medic Blood Sample taken in relation to thyroid function 
1 Nursing  Health Check (including Mental Health) 
Urine Sample taken to check for thyroid function and infection.   




Podiatrist  OK Health Check 




Dietician OK Health Check 
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Weight, height and BMI measured 
Physiotherapist  OK Health Check 
Physical ability screen – includes posture, joint range of movement & gait 
assessment 





Dementia Screening Assessment – The Cambridge Examination for Mental 
Disorders of Older People with Down's Syndrome and Others with 
Intellectual Disabilities (CAMSEX-DS); Dementia Questionnaire for 
people with a Learning Disability (DLD); Adaptive Behaviour Dementia 
Questionnaire (ABDQ) 
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